A detailed history of American International Group, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, American International Group, Inc. holds 9,062 shares of LGND stock, worth $768,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,062
Previous 9,144 0.9%
Holding current value
$768,366
Previous $653,000 1.38%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$68.64 - $89.2 $5,628 - $7,314
-82 Reduced 0.9%
9,062 $662,000
Q4 2023

Feb 13, 2024

BUY
$49.57 - $72.63 $743 - $1,089
15 Added 0.16%
9,144 $653,000
Q3 2023

Nov 13, 2023

BUY
$58.86 - $72.67 $11,301 - $13,952
192 Added 2.15%
9,129 $547,000
Q2 2023

Aug 04, 2023

BUY
$69.53 - $79.33 $43,247 - $49,343
622 Added 7.48%
8,937 $644,000
Q1 2023

May 12, 2023

BUY
$65.67 - $77.08 $1,970 - $2,312
30 Added 0.36%
8,315 $611,000
Q4 2022

Feb 10, 2023

SELL
$61.72 - $96.74 $4,011 - $6,288
-65 Reduced 0.78%
8,285 $553,000
Q3 2022

Nov 14, 2022

BUY
$0.01 - $107.56 $0 - $3,119
29 Added 0.35%
8,350 $719,000
Q2 2022

Aug 12, 2022

SELL
$74.52 - $117.06 $33,086 - $51,974
-444 Reduced 5.07%
8,321 $742,000
Q1 2022

May 13, 2022

SELL
$94.99 - $151.56 $50,344 - $80,326
-530 Reduced 5.7%
8,765 $986,000
Q4 2021

Feb 11, 2022

SELL
$127.69 - $165.85 $38,179 - $49,589
-299 Reduced 3.12%
9,295 $1.44 Million
Q3 2021

Nov 12, 2021

SELL
$102.33 - $144.73 $2.89 Million - $4.09 Million
-28,230 Reduced 74.64%
9,594 $1.34 Million
Q2 2021

Aug 13, 2021

SELL
$113.03 - $155.64 $55,497 - $76,419
-491 Reduced 1.28%
37,824 $4.96 Million
Q1 2021

May 07, 2021

BUY
$99.52 - $215.83 $111,561 - $241,945
1,121 Added 3.01%
38,315 $5.84 Million
Q4 2020

Feb 12, 2021

SELL
$80.55 - $106.05 $55,740 - $73,386
-692 Reduced 1.83%
37,194 $3.7 Million
Q3 2020

Nov 04, 2020

SELL
$89.56 - $126.72 $64,124 - $90,731
-716 Reduced 1.85%
37,886 $3.61 Million
Q2 2020

Aug 12, 2020

SELL
$68.28 - $123.65 $235,566 - $426,592
-3,450 Reduced 8.2%
38,602 $4.32 Million
Q1 2020

May 04, 2020

SELL
$63.37 - $107.88 $144,927 - $246,721
-2,287 Reduced 5.16%
42,052 $3.06 Million
Q4 2019

Feb 05, 2020

SELL
$96.94 - $113.59 $341,519 - $400,177
-3,523 Reduced 7.36%
44,339 $4.62 Million
Q3 2019

Nov 08, 2019

SELL
$86.25 - $120.16 $194,580 - $271,080
-2,256 Reduced 4.5%
47,862 $4.76 Million
Q2 2019

Aug 13, 2019

SELL
$107.38 - $129.34 $391,292 - $471,314
-3,644 Reduced 6.78%
50,118 $5.72 Million
Q1 2019

May 06, 2019

SELL
$105.93 - $142.47 $312,175 - $419,859
-2,947 Reduced 5.2%
53,762 $6.76 Million
Q4 2018

Feb 13, 2019

BUY
$128.36 - $272.13 $5.17 Million - $11 Million
40,260 Added 244.76%
56,709 $7.7 Million
Q3 2018

Nov 09, 2018

BUY
$211.18 - $274.49 $59,763 - $77,680
283 Added 1.75%
16,449 $4.52 Million
Q2 2018

Aug 08, 2018

BUY
$150.77 - $207.98 $461,657 - $636,834
3,062 Added 23.37%
16,166 $3.35 Million
Q1 2018

May 07, 2018

SELL
$138.63 - $182.62 $452,765 - $596,436
-3,266 Reduced 19.95%
13,104 $2.16 Million
Q4 2017

Feb 09, 2018

BUY
$128.36 - $147.04 $11,295 - $12,939
88 Added 0.54%
16,370 $2.24 Million
Q3 2017

Nov 09, 2017

BUY
$120.91 - $137.94 $1.97 Million - $2.25 Million
16,282
16,282 $2.22 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.43B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.